Breaking News, Financial News

Financial Report: Novartis 2Q

Recently launched products generated sales of $2.4 billion, 21% of total sales, including A(H1N1) pandemic vaccines.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novartis 2Q

2Q Revenues: $11.7 billion (+11%)

2Q Earnings: $2.4 billion (+19%)

YTD Revenues:
$23.8 billion (+18%)

YTD Earnings:
$5.4 billion (+29%)

Comments:
Recently launched products generated sales of $2.4 billion, 21% of total sales, including A(H1N1) pandemic vaccines. Pharmaceuticals revenue was $7.7 billion, up 8%. Vaccines and Diagnostics sales were $0.6 billion, up 135%, which included $0.2 billion of A(H1N1) pandemic vaccine sales. Sandoz sales were $2.0 billion, up 13%, attributed to new product launches and the contribution of EBEWE Pharma.


Keep Up With Our Content. Subscribe To Contract Pharma Newsletters